Tokyo, Japan

Dai Kurihara

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 2021.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dai Kurihara: Innovator in Polymer Derivatives

Introduction

Dai Kurihara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of polymer chemistry, particularly in the development of drug delivery systems. His innovative work focuses on enhancing the effectiveness of pharmacological treatments through advanced polymeric micelles.

Latest Patents

Dai Kurihara holds a patent for an "Active-targeting-type polymer derivative, composition containing said polymer derivative, and uses of said polymer derivative and said composition." This patent describes a polymeric micelle type drug delivery system (DDS) that improves the pharmacological activity of substances by enhancing their migration, penetrability, and retention towards diseased tissues, such as tumors or inflammation-affected areas. The invention involves a block copolymer that combines hydrophilic and hydrophobic segments, specifically designed to target and bind to specific sites within the body.

Career Highlights

Dai Kurihara is associated with Nippon Kayaku Kabushiki Kaisha, a company known for its advancements in pharmaceuticals and chemicals. His work at this organization has allowed him to focus on innovative solutions that address critical medical challenges.

Collaborations

Throughout his career, Dai has collaborated with esteemed colleagues, including Keiichirou Yamamoto and Tsuyoshi Fukuda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of polymer science.

Conclusion

Dai Kurihara's contributions to polymer derivatives and drug delivery systems exemplify the impact of innovation in the medical field. His work continues to pave the way for advancements that enhance treatment efficacy and patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…